dapi has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
DAPI: RN given refers to parent cpd.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Su, X | 1 |
Wang, X | 1 |
Liu, Q | 1 |
Wang, P | 1 |
Xu, C | 1 |
Leung, AW | 1 |
Rodley, P | 1 |
McDonald, M | 1 |
Price, B | 1 |
Fright, R | 1 |
Morris, C | 1 |
2 other studies available for dapi and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
The role of Beclin 1 in SDT-induced apoptosis and autophagy in human leukemia cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspase 3; Fluorescent Dyes; Gene Kno | 2015 |
Comparative genomic hybridization reveals previously undescribed amplifications and deletions in the chronic myeloid leukemia-derived K-562 cell line.
Topics: Female; Fluorescent Dyes; Gene Amplification; Gene Deletion; Humans; Image Processing, Computer-Assi | 1997 |